Skip to main content

Day: September 25, 2020

Siyata Mobile Announces Pricing of its Upsized US$12.6 Million U.S. Initial Public Offering

MONTREAL, Sept. 25, 2020 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (TSX-V:SIM) (OTCQX:SYATF) (FRA: WK3D) (NasdaqCM: SYTA, SYTAW) (“Siyata” or the “Company”) today announced the pricing of its U.S. initial public offering of 2,100,000 units at a price of US$6.00 per unit. Each unit consists of one common share and one warrant to purchase one common share. The common shares and warrants are immediately separable from the units and will be issued separately.   The common shares and warrants have been approved to list on the Nasdaq Capital Market under the symbols “SYTA” and “SYTAW,” respectively, and are expected to begin trading on September 25, 2020. Siyata expects to receive gross proceeds of approximately US$12.6 million, before deducting underwriting discounts and commissions and other estimated offering expenses.The warrants are...

Continue reading

Dollar Mutual Bancorp to Acquire Standard AVB Financial Corp.

PITTSBURGH and MONROEVILLE, Pa., Sept. 25, 2020 (GLOBE NEWSWIRE) — Dollar Mutual Bancorp (“Dollar”) and Standard AVB Financial Corp. (“Standard”) (NASDAQ: STND) jointly announced the signing of a definitive merger agreement pursuant to which Dollar will acquire Standard, the Monroeville, Pennsylvania based holding company and parent of Standard Bank, PaSB in an all cash transaction for an aggregate purchase price of $158 million.Under the terms of the merger agreement, which has been approved unanimously by the boards of directors of both companies, stockholders of Standard will be entitled to receive $33.00 in cash for each share of Standard common stock they own.“We are delighted to have Standard Bank join the Dollar family, we feel this is an excellent fit. We share the same core values, commitment to our customers and...

Continue reading

Ultragenyx to Present at Jefferies Gene Therapy/Editing Summit

NOVATO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will hold a virtual presentation at the Jefferies Virtual Gene Therapy/Editing Summit on Friday, October 2, 2020 at 1:00 PM ET.The live and archived webcast of the presentation will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 90 days.About Ultragenyx Pharmaceutical Inc.Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare...

Continue reading

BTHR Announces its October Tournament Schedule

TAMPA, FL, Sept. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Sports Venues of Florida, Inc., (OTCMKTS: BTHR) (“Sports Venues of Florida”, “BTHR”, or the “Company”), an emerging leader in the youth sports, family sports entertainment, and eSports markets, is announcing its October 2020 eSports gaming tournament schedule. The Shadow Gaming, Inc., October schedule is packed with great independent studios games with a variety of titles that our player base will love, starting with Darkest Dungeon game on October 3. This game is a challenging gothic RPG about the stresses of dungeon crawling. The game leads you into a band of heroes on a perilous side-scrolling descent, dealing with a prodigious number of threats to their bodily health, and worse, a relentless assault on their mental fortitude! October 4th, we have Fall Guys...

Continue reading

Collegium Appoints Rita Balice-Gordon to its Board of Directors

STOUGHTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to its Board of Directors, effective September 24, 2020.“Collegium is honored to welcome Rita to our Board of Directors,” said Mike Heffernan, Founder and Chairman of the Board of Collegium. “Rita’s impressive scientific expertise and industry experience will be incredibly valuable for the Company. We are confident that she will make meaningful contributions to our Board of Directors and that Collegium will benefit from her insights as we continue our commitment to leadership in responsible pain management.”“I am excited for the opportunity to join Collegium’s Board during this important...

Continue reading

The First of Long Island Corporation Announces 5.6% Increase in Quarterly Cash Dividend to $.19 per Share

GLEN HEAD, N.Y., Sept. 25, 2020 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC) announced today the declaration of a third quarter cash dividend in the amount of $.19 per share. This represents a 5.6% increase over the dividend of $.18 per share declared in the same quarter last year. The dividend will be paid on October 22, 2020 to shareholders of record on October 13, 2020.The First National Bank of Long Island is the sole subsidiary of The First of Long Island Corporation. The Bank currently has forty-nine branches in Nassau and Suffolk Counties, Long Island and the boroughs of Queens, Brooklyn and Manhattan.For More Information Contact:Jay McConie, EVP & CFO(516) 671-4900, Ext. 7404

Continue reading

Notice of third quarter 2020 results and conference call

Notice of third quarter 2020 results and conference call Luxembourg, September 25, 2020 – Millicom will announce its third quarter results on October 30, 2020 at approximately 11:00 (Stockholm) / 10:00 (London) / 06:00 (Miami) via a press release.The company will host a conference call for the global financial community on October 30, 2020 at 13:00 (Stockholm) / 12:00 (London) / 08:00 (Miami).The conference call will be webcast at millicom.comDial-in information:Please dial in 5-10 minutes before the scheduled start time to register your attendance. Dial-in numbers for the call are as follows:Sweden:          +46 (0) 8566-19361                            Luxembourg:  +352-2786-6996UK:                  +44 (0) 2031-070289                          US:                   +1-914-987-7208The access code is: 4064116Replay information:A replay...

Continue reading

YANGAROO Announces The Launch Of EZ Downloads; Software-Free Secure Watermarked Cloud-Based Downloads

TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — YANGAROO Inc. (“Yangaroo”, “Company”), (TSX-V: YOO, OTCBB: YOOIF), the software leader in workflow management and media distribution solutions, today announced the launch of a major upgrade to its cloud-based Yangaroo Music distribution platform. The Yangaroo Music platform runs on Yangaroo’s DMDS workflow solution for Media and Entertainment companies based entirely in the cloud. DMDS users, including professionals in radio, media and other promotional music outlets, are now able to download new music and accompanying promo assets directly through their web browser with the same efficiency and security as using the existing application interface. This update has been dubbed EZ Downloads and provides a significant market advantage over competing services, making Yangaroo Music and DMDS...

Continue reading

Cabaletta Bio to Present at Upcoming Investor Conferences in October

PHILADELPHIA, Sept. 25, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the following three upcoming investor conferences in October:Stifel 2020 Immunology and Inflammation Virtual Summit: “The Potential for Treg Modifying and CAR T Therapies in Immunology” panel on Thursday, October 1, 2020 at 3:00 p.m. ET.Jefferies Virtual Cell Therapy Summit: Fireside chat on Monday, October 5, 2020 at 8:30 a.m. ET.Chardan 4thAnnual Genetic Medicines Conference: Fireside chat on Tuesday, October 6, 2020 at 11:30 a.m. ET.A live webcast of these presentations will be available...

Continue reading

Graybug Appoints Three New Members to its Board of Directors

REDWOOD CITY, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the appointment of three new members to the company’s Board of Directors with immediate effect. Christina Ackermann will chair Graybug’s Nominating and Corporate Governance Committee and serve as a member of its Compensation Committee. Eric Bjerkholt, MBA, will chair the company’s Compensation Committee and serve as a member of the Audit Committee. Julie Eastland, MBA, will chair the Audit Committee.Ms. Ackermann, Mr. Bjerkholt and Ms. Eastland replace Emmett Cunningham, Jr., MD, PhD, Managing Director at Blackstone Lifesciences Group, Chau Q. Khuong, MPH, Partner...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.